glp-1 in type 1 diabetes Frontiers Good News: GLP-1 Medications in

[DOI] [PubMed] [Google Scholar] Malaisse WJ, Louchami K, Sener A

Monitoring and Managing Patients on GLP1s Implementing GLP1 MASLD MASH treatment requires structured follow-up

Clinical Scoring Systems The U.S

According to data from a Kings Fund report, more than 800,000 GLP-1 items were prescribed in 2025, compared to around 100,000 in 2020

Types of GLP-1 medications GLP-1 therapies are available in several different forms: Once-weekly injections Daily oral or injectable options Combination therapy with insulins Xultophy (insulin degludec + liraglutide) IcoSema (weekly insulin Icodec + Semaglutide) Soliqua (insulin glargine and lixisenatide) How the main GLP-1 drugs compare While all GLP-1 medications work through similar mechanisms, they differ in strength, dosing frequency, weight loss effects, and side-effect profiles

That projection was subsequently tested against real-world data